ReferenceRRK6600

A Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy and Safety of ST-0529 in Subjects with Moderately to Severely Active Ulcerative Colitis.

Research Summary

Research Overview
PI Name Iqbal - T
Speciality
Project Status Open
Proposed End Date 31/12/2020
Study Run through CRF? Yes
Target number of patients agreed to recruit 3
Recruitment so far 0